First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes

被引:55
作者
Chase, HP
Cuthbertson, DD
Dolan, LM
Kaufman, F
Krischer, JP
Schatz, DA
White, NH
Wilson, DM
Wolfsdorf, J
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[3] Univ Cincinnati, Childrens Hosp, Cincinnati, OH USA
[4] Univ Calif Los Angeles, Childrens Hosp Los Angeles, Los Angeles, CA USA
[5] Univ Florida, Gainesville, FL USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Stanford Univ, Palo Alto, CA 94304 USA
[8] Harvard Univ, Childrens Hosp, Boston, MA 02115 USA
关键词
D O I
10.1067/mpd.2001.111274
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To determine the relationship between first-phase (1 minute + 3 minutes) insulin production during the intravenous glucose tolerance test (TV-GTT) and risk factors for developing type 1 diabetes. Study design: Relatives of persons with type 1 diabetes (n = 59,600) were screened for islet cell antibodies (ICAs). Subjects who had positive screening results underwent IV-GTT (greater than or equal to2 times), repeat ICA screening, insulin autoantibody (IAA) screening twice, and an oral glucose tolerance test. Results: Of the 59,600 subjects in the study, 2199 (3.69%) had positive findings on initial ICA test. IV-GTTs were performed in 1622 subjects, with children <8 years having the lowest first-phase insulin release (FPIR) and subjects 8 to 20 years of age having the highest FPIR. The FPIR was lower for subjects with a confirmed positive ICA test result or a positive IAA test result, subjects with higher titers of ICA or IAA, and subjects who had an abnormal (impaired or diabetic) oral glucose tolerance test result. Conclusion: FPIR in the IV-GTT correlates strongly with risk factors for development of type 1 diabetes.
引用
收藏
页码:244 / 249
页数:6
相关论文
共 23 条
  • [1] 1ST-PHASE INSULIN RELEASE IN NORMAL-CHILDREN
    ALLEN, HF
    JEFFERS, BW
    KLINGENSMITH, GJ
    CHASE, HP
    [J]. JOURNAL OF PEDIATRICS, 1993, 123 (05) : 733 - 738
  • [2] IMPAIRED INSULIN ACTION IN PUBERTY - A CONTRIBUTING FACTOR TO POOR GLYCEMIC CONTROL IN ADOLESCENTS WITH DIABETES
    AMIEL, SA
    SHERWIN, RS
    SIMONSON, DC
    LAURITANO, AA
    TAMBORLANE, WV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) : 215 - 219
  • [3] STANDARDIZATION OF IVGTT TO PREDICT IDDM
    BINGLEY, PJ
    COLMAN, P
    EISENBARTH, GS
    JACKSON, RA
    MCCULLOCH, DK
    RILEY, WJ
    GALE, EAM
    [J]. DIABETES CARE, 1992, 15 (10) : 1313 - 1316
  • [5] LINEAR LOSS OF INSULIN SECRETORY CAPACITY DURING THE LAST 6 MONTHS PRECEDING IDDM - NO EFFECT OF ANTIEDEMATOUS THERAPY WITH KETOTIFEN
    BOHMER, KP
    KOLB, H
    KUGLIN, B
    ZIELASEK, J
    HUBINGER, A
    LAMPETER, EF
    WEBER, B
    KOLBBACHOFEN, V
    JASTRAM, HU
    BERTRAMS, J
    GRIES, FA
    [J]. DIABETES CARE, 1994, 17 (02) : 138 - 141
  • [6] QUANTIFICATION OF ISLET-CELL ANTIBODIES AND PREDICTION OF INSULIN-DEPENDENT DIABETES
    BONIFACIO, E
    BINGLEY, PJ
    SHATTOCK, M
    DEAN, BM
    DUNGER, D
    GALE, EAM
    BOTTAZZO, GF
    [J]. LANCET, 1990, 335 (8682) : 147 - 149
  • [7] PREDICTION OF THE COURSE OF PRE-TYPE-1 DIABETES
    CHASE, HP
    GARG, SK
    BUTLERSIMON, N
    KLINGENSMITH, G
    NORRIS, L
    RUSKEY, CT
    OBRIEN, D
    [J]. JOURNAL OF PEDIATRICS, 1991, 118 (06) : 838 - 841
  • [8] DIAGNOSIS OF PRE-TYPE-1 DIABETES
    CHASE, HP
    VOSS, MA
    BUTLERSIMON, N
    HOOPS, S
    OBRIEN, D
    DOBERSEN, MJ
    [J]. JOURNAL OF PEDIATRICS, 1987, 111 (06) : 807 - 812
  • [9] INSULIN AUTOANTIBODIES IN THE PREDIABETIC PERIOD - CORRELATION WITH ISLET CELL ANTIBODIES AND DEVELOPMENT OF DIABETES
    DEAN, BM
    BECKER, F
    MCNALLY, JM
    TARN, AC
    SCHWARTZ, G
    GALE, EAM
    BOTTAZZO, GF
    [J]. DIABETOLOGIA, 1986, 29 (05) : 339 - 342
  • [10] Gavin JR, 1997, DIABETES CARE, V20, P1183